Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BA.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.560ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.311ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.93ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used